Novo Nordisk A S (NONOF) stock
NONOFOTCPharmaceutical PreparationsFiscal year ends December 31Also trades as NVO
Financials through fiscal 2025, year ended Dec 31, 2025Score 4/30
$38.24−0.60 (-1.53%)
Close on Oct 19, 2026Market cap $170.76BP/E 11.1Yield –
Novo Nordisk A S free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
For fiscal 2025 it was 58.96B DKK, down 20.1% from the year before. Over ten years it grew 6.0% a year on average. The highest annual figure on record is 83.10B DKK in fiscal 2023.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 58.96B DKK | -20.1% |
| FY2024 | Dec 31, 2024 | 73.80B DKK | -11.2% |
| FY2023 | Dec 31, 2023 | 83.10B DKK | +24.5% |
| FY2022 | Dec 31, 2022 | 66.74B DKK | +37.1% |
| FY2021 | Dec 31, 2021 | 48.67B DKK | +5.5% |
| FY2020 | Dec 31, 2020 | 46.13B DKK | +21.9% |
| FY2019 | Dec 31, 2019 | 37.85B DKK | +8.2% |
| FY2018 | Dec 31, 2018 | 34.98B DKK | +4.3% |
| FY2017 | Dec 31, 2017 | 33.54B DKK | -18.7% |
| FY2016 | Dec 31, 2016 | 41.25B DKK | +24.7% |
| FY2015 | Dec 31, 2015 | 33.06B DKK | – |
See a number that looks wrong?